NDA 17549, held by Meridian Medcl Techn. Lidocaine Hydrochloride.
As of Nov 13, 2026, NDA 17549 (Lidopen), held by Meridian Medcl Techn, was first approved by FDA on Mar 28, 1975, with 16 approved supplements and 0 published complete response letters.
| Oct 18, 1976 | Supplement 3Efficacy (new indication or use) | Approved | None posted |
| Mar 28, 1975 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidopen10% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Oct 31, 2002 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Oct 20, 2000 | Supplement 19Manufacturing · Standard review | Approved | None posted |
| Dec 8, 1999 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Jul 21, 1998 | Supplement 17Manufacturing · Standard review | Approved | None posted |
| Apr 18, 1997 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Jan 9, 1997 | Supplement 15Manufacturing · Standard review | Approved | None posted |
| Jun 6, 1996 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| May 10, 1993 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Dec 23, 1988 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Dec 10, 1986 | Supplement 11Labeling | Approved | None posted |
| Apr 16, 1984 | Supplement 8Labeling | Approved | None posted |
| Jan 11, 1978 | Supplement 7Labeling | Approved | None posted |
| Mar 17, 1977 | Supplement 4Labeling | Approved | None posted |
| Oct 18, 1976 | Supplement 3Efficacy (new indication or use) | Approved | None posted |
| Dec 4, 1975 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Sep 24, 1975 | Supplement 1Labeling | Approved | None posted |
| Mar 28, 1975 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters